Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Treatment Type
     • Market Snapshot, By Distribution Channel
     • Market Snapshot, By Application
     • Market Snapshot, By End User
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
       • Rising awareness regarding the importance of women’s health
       • Growing prevalence of atrophic vaginitis
       • Availability of effective treatments
     • Restraints
       • Side-effects of hormone therapy
       • Delay in diagnosis mostly in underdeveloped countries
     • Opportunities
       • Increasing elderly population
       • Growing initiatives to raise awareness regarding women’s health
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
   • Product launch/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Merger and Acquisition Scenario
4. Global Atrophic Vaginitis Treatment Market – Impact of Coronavirus (COVID-19) Pandemic
   • COVID-19 Epidemiology
   • Supply Side and Demand Side Analysis
   • Economic Impact
5. Global Atrophic Vaginitis Treatment Market , By Treatment Type, 2017-2030, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2017 – 2030
     • Segment Trends
   • Hormonal Therapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
   • Non-Hormonal Therapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
   • Laser Therapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
6. Global Atrophic Vaginitis Treatment Market , By Distribution Channel, 2017-2030, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2017 – 2030
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
7. Global Atrophic Vaginitis Treatment Market , By Application, 2017-2030, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2017 – 2030
     • Segment Trends
   • Vaginal dryness
     
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
   • Vaginal burning
     
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
8. Global Atrophic Vaginitis Treatment Market , By End User, 2017-2030, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2017 – 2030
     • Segment Trends
   • Hospitals
     
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
   • Clinics
     
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
   • Home care settings
     
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
9. Global Atrophic Vaginitis Treatment Market , By Region, 2017-2030, (US$ Mn)
   • Introduction
     • Market Share Analysis, By Country, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, For Country 2017–2030
     • Country Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
   • Middle East & Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
10. Competitive Landscape
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • TherapeuticsMD Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Allergan plc (AbbVie Inc.)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Duchesnay USA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Novo Nordisk A/S
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Endoceutics Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bausch Health Companies Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Mylan N.V.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views
11. Section
    • Research Methodology
    • About us

*Browse 24 market data tables and 28 figures on "ATROPHIC VAGINITIS TREATMENT Market” - Global forecast to 2030